Evaluation of the Prescribing Skills Assessment implementation, performance and medical student experience in Australia and New Zealand

Show simple item record

dc.contributor.author Chin, Paul KL
dc.contributor.author Charles, Kellie
dc.contributor.author Murnion, Bridin
dc.contributor.author McGuire, Treasure M
dc.contributor.author Hilmer, Sarah N
dc.contributor.author Martin, Jennifer
dc.contributor.author Reith, David
dc.contributor.author Joyce, David
dc.contributor.author Lucas, Catherine
dc.contributor.author Holford, Nick
dc.contributor.author Day, Richard
dc.contributor.author Schneider, Jennifer
dc.contributor.author Doogue, Matthew
dc.contributor.author Han, Catherine H
dc.contributor.author Herd, Sarah
dc.contributor.author Harrison, Claire
dc.contributor.author O'Mara, Deborah
dc.coverage.spatial England
dc.date.accessioned 2023-11-06T22:30:04Z
dc.date.available 2023-11-06T22:30:04Z
dc.date.issued 2023-10
dc.identifier.citation (2023). British Journal of Clinical Pharmacology, 89(10), 3105-3115.
dc.identifier.issn 0306-5251
dc.identifier.uri https://hdl.handle.net/2292/66490
dc.description.abstract Aims: The UK Prescribing Safety Assessment was modified for use in Australia and New Zealand (ANZ) as the Prescribing Skills Assessment (PSA). We investigated the implementation, student performance and acceptability of the ANZ PSA for final-year medical students. Methods: This study used a mixed-method approach involving student data (n = 6440) for 2017–2019 (PSA overall score and 8 domain subscores). Data were also aggregated by medical school and included student evaluation survey results. Quantitative data were analysed using descriptive and multivariate analyses. The pass rate was established by a modified Angoff method. Thematic analyses of open-ended survey comments were conducted. Results: The average pass rate was slightly higher in 2017 (89%) which used a different examination to 2018 (85%) and 2019 (86%). Little difference was identified between schools for the PSA overall performance or domain subscores. There was low intercorrelation between subscores. Most students provided positive feedback about the PSA regarding the interface and clarity of questions, but an average of 35% reported insufficient time for completion. Further, 70% on average felt unprepared by their school curricula for the PSA, which is in part explained by the low prescribing experience; 69% reported completing ≤10 prescriptions during training. Conclusion: The ANZ PSA was associated with high pass rates and acceptability, although student preparedness was highlighted as a concern for further investigation. We demonstrate how a collaboration of medical schools can adapt a medical education assessment resource (UK PSA) as a means for fulfilling an unmet need.
dc.format.medium Print-Electronic
dc.language eng
dc.publisher Wiley
dc.relation.ispartofseries British journal of clinical pharmacology
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject Humans
dc.subject Curriculum
dc.subject Education, Medical, Undergraduate
dc.subject Clinical Competence
dc.subject Schools, Medical
dc.subject Students, Medical
dc.subject Australia
dc.subject New Zealand
dc.subject Surveys and Questionnaires
dc.subject assessment
dc.subject clinical pharmacology
dc.subject education
dc.subject error
dc.subject medication safety
dc.subject prescribing
dc.subject undergraduate
dc.subject 3214 Pharmacology and Pharmaceutical Sciences
dc.subject 32 Biomedical and Clinical Sciences
dc.subject Science & Technology
dc.subject Life Sciences & Biomedicine
dc.subject Pharmacology & Pharmacy
dc.subject SAFE
dc.subject 1115 Pharmacology and Pharmaceutical Sciences
dc.title Evaluation of the Prescribing Skills Assessment implementation, performance and medical student experience in Australia and New Zealand
dc.type Journal Article
dc.identifier.doi 10.1111/bcp.15814
pubs.issue 10
pubs.begin-page 3105
pubs.volume 89
dc.date.updated 2023-10-26T12:15:55Z
dc.rights.holder Copyright: The authors en
dc.identifier.pmid 37276579 (pubmed)
pubs.author-url https://www.ncbi.nlm.nih.gov/pubmed/37276579
pubs.end-page 3115
pubs.publication-status Published
dc.rights.accessrights http://purl.org/eprint/accessRights/OpenAccess en
pubs.subtype Research Support, Non-U.S. Gov't
pubs.subtype Journal Article
pubs.elements-id 964124
pubs.org-id Medical and Health Sciences
pubs.org-id Medical Sciences
pubs.org-id Pharmacology
dc.identifier.eissn 1365-2125
pubs.record-created-at-source-date 2023-10-27
pubs.online-publication-date 2023-06-22


Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics